Ledger.Open graph →
SEC Form D · Amendment · filed March 8, 2024

Curavit Clinical Research Corp

Offering
$10.4M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SCARSDALE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joel Morse · Scarsdale, NYExec · DirectorJackie Kent · Scarsdale, NYDirectorRich Lester · Scarsdale, NYDirectorNathanael Lentz · Scarsdale, NYDirectorDavid Hanaman · Scarsdale, NYDirectorJackie Kent · Scarsdale, NYDirectorJohn D. Haymes · Columbus, OHExec · DirectorLogan Rutledge · Cedar City, UTDirectorAmar Dedhia · Jersey City, NJDirectorJamir Savla · Jersey City, NJDirectorDevang Kantesaria · Miami, FLDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorMichael Kelly · NEW YORK, NYExec · DirectorDrew L. Wellsfry · Dallas, TXDirectorJames Clifton · Pleasanton, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗